The University of Amsterdam (UVA) has agreed to license a hybrid stereolithography (SLA) technology to Digital Light Processing (DLP) 3D printer manufacturer atum3D.
Developed at the university’s Van ‘t Hoff Institute for Molecular Sciences, this hybrid SLA process combines photo and stereolithography to enable the production of parts with high-resolution features at scale. Once commercialized, the UVA says the technology could be used to address medical R&D needs, such as the creation of tissue scaffolds or microfluidic devices with clinical research applications.
atum3D’s DLP 3D printing portfolio
Based in the city of Gouda in the Netherlands, atum3D specializes in the development of DLP technologies designed to address serial manufacturing applications. The firm’s main offering revolves around the DLP Station…
